26902 | Last Updated 12-28-2013 Disclaimer The disclaimer | testuser | 04/11/2014 9:13:34 PM |
26901 | Terms And Conditions Terms of use If you are a | testuser | 04/11/2014 9:12:08 PM |
26900 | Your use of the Investors Hangout Website | testuser | 04/11/2014 9:10:50 PM |
26899 | test pic | acc724 | 04/11/2014 8:56:11 PM |
26898 | test | acc724 | 04/11/2014 8:54:29 PM |
26897 | pic test.. | acc724 | 04/11/2014 8:52:17 PM |
26896 | test | acc724 | 04/11/2014 8:51:32 PM |
26895 | Terms And Conditions Terms of use If you are a | testuser | 04/11/2014 6:36:15 PM |
26894 | testr0989808 | testuser | 04/11/2014 2:53:45 PM |
26893 | abc abc | itest | 04/11/2014 12:34:59 PM |
26892 | &&&&&&&&& | itest | 04/11/2014 12:17:17 PM |
26891 | test etst test test Underline | itest | 04/11/2014 11:47:20 AM |
26890 | test test test | itest | 04/11/2014 10:21:13 AM |
26889 | Untitled Document asdads as das | itest | 04/11/2014 9:56:02 AM |
26888 | abc abc abc | itest | 04/11/2014 9:22:51 AM |
26887 | http://investorshangout.com/post/newpost/1868 | itest | 04/11/2014 8:54:57 AM |
26886 | Last Updated 2/10/2014 6:30 PM | itest | 04/11/2014 8:50:39 AM |
26885 | itest | 04/11/2014 6:38:42 AM | |
26884 | Last Updated 2/10/2014 6:30 PM Your use of the | itest | 04/11/2014 2:19:25 AM |
26883 | One Two | testuser | 04/10/2014 7:10:00 PM |
26882 | "InvestorsHangout.com" | testuser | 04/10/2014 4:33:22 PM |
26881 | delete | testuser | 04/10/2014 4:31:39 PM |
26880 | Terms And Conditions Terms of use If you are a | testuser | 04/10/2014 4:26:40 PM |
26879 | ok L | testuser | 04/10/2014 4:07:38 PM |
26877 | IL LLLL Fields with * are | itest | 04/10/2014 6:05:36 AM |
26876 | Your use of the Investors Hangout Website | itest | 04/10/2014 5:49:11 AM |
26875 | very very good work. | testuser | 04/09/2014 8:21:29 PM |
26874 | "test" | testuser | 04/09/2014 8:02:52 PM |
26873 | IL LLLL | testuser | 04/09/2014 7:05:48 PM |
26872 | testing i123212 | testuser | 04/09/2014 5:05:25 PM |
26871 | L | testuser | 04/09/2014 5:05:15 PM |
26870 | i:L | testuser | 04/09/2014 5:04:01 PM |
26868 | helli from mobile | itest | 04/09/2014 8:39:24 AM |
26867 | test test | testuser | 04/09/2014 5:52:41 AM |
26866 | http://investorshangout.com/ insert-text-here | testuser | 04/09/2014 5:50:16 AM |
26865 | looks good | testuser | 04/09/2014 5:48:00 AM |
26864 | b test i test Insert-tag-here | testuser | 04/09/2014 5:46:22 AM |
26863 | b test i test Insert-tag-here | testuser | 04/09/2014 5:45:26 AM |
26862 | testing | testuser | 04/09/2014 5:44:25 AM |
26861 | testing <script async | testuser | 04/09/2014 5:44:00 AM |
26860 | http://investorshangout.com/images/Investors-Hang | itest | 04/09/2014 3:59:29 AM |
26859 | http://investorshangout.com/ insert-text-here | itest | 04/09/2014 2:46:59 AM |
26858 | Sym Name Std Dev Last Change Percent High Low | itest | 04/09/2014 2:14:27 AM |
26857 | <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML | itest | 04/09/2014 1:51:51 AM |
26856 | Untitled Document asdads as das asd | itest | 04/09/2014 1:42:39 AM |
26855 | kgmu test | itest | 04/09/2014 1:33:53 AM |
26854 | KGMUCU | itest | 04/09/2014 1:30:42 AM |
26853 | test | itest | 04/09/2014 12:26:21 AM |
26852 | Sym Name Std Dev Last Change Percent High Low | itest | 04/09/2014 12:24:34 AM |
26851 | looking good. | testuser | 04/08/2014 9:51:20 PM |
Recent Articles
- Revolutionizing In-Car Audio: Audiokinetic's Role in NEVO E07
- FibroBiologics Q3 2024 Results: Advancements in Cell Therapy
- American Healthcare REIT Boosts 2024 Guidance Amid New Acquisitions
- Upcoming TEN, Ltd. Conference Call for Q3 Earnings and Webcast
- Tempest Therapeutics Unveils Progress and Financial Insights
- Sempra Earns Spot as a Top Global Company for 2024 Recognition
- CarGurus Embraces Opportunity at RBC Capital Markets Conference
- UTI-Canton Recognized as a Veteran-Friendly Educational Hub
- Willow Lane Acquisition Corp. Successfully Completes IPO
- Thunder Bridge Capital Partners IV Moves Forward with Coincheck Merger
- ONEOK's Upcoming Participation in Global Energy Conference
- Nature's Miracle Holding Inc. Completes $3 Million Offering
- Kentucky First Federal Bancorp's Latest Earnings Analysis
- Matson's Upcoming Presentation at Investment Conference
- LGI Homes Launches $400 Million Senior Notes Offering
- SurgePays' Q3 2024 Results Reveal Strategic Growth Path
- Hyperfine, Inc. Sees Significant Growth in Third Quarter
- Topgolf Callaway Brands Exceeds Q3 2024 Expectations
- ReShape Lifesciences' Q3 Financial Announcements and Updates
- FibroGen Shows Promising Growth with Latest Financial Report
- CNB Financial Corporation Declares Significant Quarterly Dividend
- Select Water Solutions Engages in Fireside Chat Series
- Locafy Limited: Highlights from Fiscal Year 2024 Performance
- PubMatic Reports Impressive Growth in Q3 Financial Results
- Psychemedics Corporation Reports Q3 Insights and Future Outlook
- Runway Growth Finance Corp. Exhibits Strong Q3 Results
- Lifecore Biomedical Set to Showcase at Investment Conference
- Fractyl Health's Q3 2024 Financial Insights and Operational Updates
- Perspective Therapeutics: Significant Developments and Fiscal Updates
- Urgently's Q3 2024 Performance Highlights and Future Outlook
- Codexis Welcomes Dr. Raymond De Vré to Its Board of Directors
- GEN Restaurant Group Reports Strong Q3 Performance in 2024
- W. P. Carey Inc. Successfully Prices €600 Million Senior Notes
- Crinetics Pharmaceuticals Unveils Neuroendocrine Tumor Advances
- Rocket Companies Reports Strong Q3 Performance and Growth
- SI-BONE Achieves Impressive Growth in Recent Financial Report
- Integral Ad Science Shows Robust Performance in Q3 2024
- Safe Harbor Financial Shows Growth in Recent Financial Results
- Genpact Welcomes Jinsook Han as Chief Strategy Officer
- Alpine Income Property Trust Boosts Investment Strategy in 2024
- Etsy to Engage Investors at Key Conferences Soon
- Pure Storage Prepares for Q3 2025 Financial Conference Call
- Dave Inc. Reports Record Growth in Financial Results
- Radiant Logistics Sees Growth Amid Economic Challenges
- Orchestra BioMed Achieves Key Financial and Operational Progress
- ICU Medical and Otsuka Forge Alliance for Advanced IV Solutions
- Viking Therapeutics Excited to Share VK2809 Phase 2b Findings
- Theravance Biopharma's Q3 2024 Results & Future Vision
- Biohaven's Strategic Advances and Financial Insights for Q4 2024
- AllianceBernstein Reports Decrease in AUM for October 2024